首页> 外文期刊>中国癌症研究(英文版) >EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PRIMARY NON-SMALL CELL LUNG CARCINOMA
【24h】

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PRIMARY NON-SMALL CELL LUNG CARCINOMA

机译:血管内皮生长因子在原发性非小细胞肺癌中的表达

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Tumor growth depends on angiogenesis.The aim of this paper is to clarify the relationship between the expression of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) and the angiogenesis, or growth, or invasion and prognostic value in Non-Small Cell Lung Cancer (NSCLC).Methods: Microvessei quantification and expression of VEGF was performed immunohistochemically, using multiclonal antibodies against endothelial protein factor Ⅷ-related antigen (F-Ⅷ antigen, or factor Ⅷ) for evaluating the angiogenesis; against VEGF antigen for the expression of VEGF. Results: A total of 53 patients with NSCLC after the radical resection were evaluated.The patients with high and low expression of VEGF were 33 and 20, respectively. A significant higher microvessel density (MVD) was observed in the tumors with high expression of VEGF compared with the tumors with low expression of it (12.17±2.57/mm2 vs 6.01±1.161/mm2, rank sum test, P<0.01). There were 29patients with lymphonodes metastasis in the high expression VEGF/VPF (29/33, 87.88%) group, and 9patients in the low (9/20, 45%) group. There was good correlation between MVD and expression of VEGF (chisquare tests, P<0.001). The overall 5 years survival for 53 patients was 20.75±5.78%; that of the high expression of the VEGF group was 3.03±2.98%; that of the low group was 36.36±13.94%, by Log rank test, P=0.0001.The difference between them had a high significance.There was good correlation between the survival and the expression of VEGF. By the COX's proportional hazard model analysis, the expression of VEGF and MVD was considered to be an independent marker of the prognosis in non-small cell lung cancer. Conclusion: the expression of VEGF has a significant correlation with MVD, growth, invasion, and lymph node metastasis. The increasing of the node metastasis and the size of tumor accompanied the increasing of VEGF/VPF. The cancer patient with higher VEGF and MVD expression might have worse prognosis. By multivariate analysis,VEGF/VPF or MVD may be taken as the independentpredictors of prognosis for NSCLC.
机译:目的:肿瘤的生长取决于血管生成。本文旨在阐明血管内皮生长因子(VEGF)/血管通透性因子(VPF)的表达与非小细胞肺癌的血管生成,生长或侵袭及预后价值之间的关系。方法:采用抗内皮蛋白因子相关抗原(F-Ⅷ抗原,或multi因子)的多克隆抗体,通过免疫组织化学法对VEGF的微血管定量和表达进行评估。针对VEGF抗原的表达。结果:对53例NSCLC患者行根治性切除术,其中VEGF高表达和低表达分别为33例和20例。高表达VEGF的肿瘤与低表达VEGF的肿瘤相比,微血管密度(MVD)显着更高(12.17±2.57 / mm2 vs 6.01±1.161 / mm2,秩和检验,P <0.01)。高表达VEGF / VPF组有29例淋巴结转移患者(29 / 33,87.88%),低表达组9例(9 / 20,45%)。 MVD与VEGF表达有良好的相关性(卡方检验,P <0.001)。 53例患者的总体5年生存率为20.75±5.78%; VEGF高表达组为3.03±2.98%。 Log Log检验显示,低组为36.36±13.94%,P = 0.0001,两者之间的差异具有较高的显着性,生存率与VEGF表达有良好的相关性。通过COX的比例风险模型分析,VEGF和MVD的表达被认为是非小细胞肺癌预后的独立指标。结论:VEGF的表达与MVD,生长,侵袭和淋巴结转移密切相关。淋巴结转移的增加和肿瘤的大小伴随着VEGF / VPF的增加。 VEGF和MVD表达较高的癌症患者预后可能较差。通过多因素分析,VEGF / VPF或MVD可作为NSCLC预后的独立预测指标。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号